by Kate Humphrey | Oct 25, 2024 1:31 pm | Biotechnology
On October 23, Merck & Co., Inc., known as MSD outside the United States and Canada, announced that it acquired Modifi Biosciences for $30 million upfront. Modifi Biosciences has developed a novel class of small molecules that target cancer cells lacking expression of a key DNA repair protein called O6-methylguanine...
Read More »